Introduction
Ceramide glucosyltransferase (Ugcg) [uridine diphosphate (UDP)-glucose:N-acylsphingosine D-glucosyltransferase or UDP-glucose ceramide glucosyltransferase (GlcT): EC 2.4.1.80] is an enzyme that transfers glucose to ceramide, yielding glucosylceramide (GlcCer). It is the key enzyme in producing GlcCer-derived glycosphingolipids (GSLs) in vertebrates . The enzyme is widely distributed throughout the animal kingdom. For example, it is found in the pathogenic fungi Cryptococcus neoformans; it plays an essential role in infection to the host alveolar spaces and bloodstream, and without this enzyme, the organism cannot complete cell-cycle progression in the host environment (Rittershaus et al. 2006) . Knockout (KO) of the gene in mice results in embryonic death at E9.5, and findings strongly indicate that the enzyme plays key roles in development and morphogenesis of multicellular organisms (Yamashita et al. 1999) . The nervous, tissue-specific knocking out of the enzyme in mice has also been assessed, showing that it is also essential in mouse brain development (Jennemann et al. 2005; Yamashita et al. 2005) . Previous work also has found that in Drosophila melanogaster, the enzyme is essential and involved in apoptosis by controlling ceramide content (Kohyama-Koganeya et al. 2004) . Although these defects in KO mice and D. melanogaster clearly show that the enzyme is indispensable, no detailed information about the roles of Ugcg at the single-cell level in the embryonic stage has been obtained because the embryonic death of the mouse and the fly is difficult to trace in vivo.
The nematode Caenorhabditis elegans is an ideal model organism for studying the roles of any indispensable genes at the single-cell level because the development of each cell can be traced thanks to the optical transparency of the embryo. To make use of this advantage, we began studying Ugcg in the nematode, reporting identification of three different orthologs of mouse and human enzymes, with each gene coding for an active enzyme synthesizing GlcCer in vitro (Ichikawa and Hirabayashi 1998) . Leipelt et al. (2000 Leipelt et al. ( , 2001 reported similar findings, and recently, Marza et al. (2009) reported that they also had identified three orthologs of the human enzyme; using deletion mutants that we had isolated, they showed that the enzymes are indispensable only in a few intestinal cells and dispensable in all other embryonic tissue cells. Although they showed clearly that the enzymes are mostly dispensable in larval-stage embryos, they did not examine the roles of the enzymes in gamete formation and in early embryonic cell division. In our work, we isolated deletion mutants lacking either cgt-1, cgt-2 or cgt-3 and examined abnormal phenotypes in these deletion mutants. As described by Marza et al., simultaneous knockdown of cgt-3 and cgt-1 resulted in a larvalstage death (L1 lethal) phenotype, but we noted that the brood size of the cgt-3 KO worm also decreased significantly. We measured the enzymatic activity of the three Ugcg orthologs (CGT-1, -2, -3) both in vivo and in vitro and found that CGT-3 is the major enzyme responsible for GlcCer synthesis. In this study, we report that KO and RNAi knockdown of the germline expression of cgt-3 results in abnormal oocyte formation and abnormal embryonic cell division. We also show that the enzymes and the production of GlcCer are indispensable in oocyte formation and early embryonic division.
Results

Comparison of enzymatic activity of each cgt genes
There are three distinct human Ugcg orthologs in the genome of C. elegans: cgt-1 (T06C12.10), cgt-2 (F20B4.6) and cgt-3 (F59G1.1) (Ichikawa and Hirabayashi 1998; Marza et al. 2009 ). To examine whether the gene products have Ugcg activity in vitro, we transfected each gene into mouse GM95 cells, which lack intrinsic Ugcg activity (Ichikawa et al. 1994) , and examined enzymatic activities in each cell homogenate. The highest enzymatic activity was observed in cgt-3-transfected cell homogenate, and GM95 cells transfected with either cgt-1 or cgt-2 showed a moderate enzymatic activity ( Figure 1A ). To confirm that the wild-type (WT) N2 worm has Ugcg activity in vivo, we measured the enzymatic activity in the worm homogenate and detected the presence of the activity in WT worms (Figure 1B, control) . We next knocked down the gene activity with RNAi treatment and measured the enzymatic activity as well as GlcCer content of each RNAi-treated worm. The independent RNAi of each gene reduced the enzymatic activity in vivo, and double RNAi of the genes resulted in more severe reduction of the enzymatic activity. Especially, a strong reduction of the activity was observed when cgt-3 was included in the RNAi experiments [ Figure 1B , black bars, P < 0.0001, one-way analysis of variance (ANOVA) and Holm's multiple comparison test]. cgt-1/cgt-2 double RNAi reduced the in vivo enzymatic activity to 60% (the Ugcg activity decreased in a statistically significant manner when compared with cgt-1 or cgt-2 single RNAi results, P < 0.0001, Figure 1B ) but the change in GlcCer content was not statistically significant. RNAi of the cgt-3 gene alone reduced the activity to 18% and GlcCer content to 48%. cgt-1/cgt-3 double RNAi reduced the enzymatic activity to 14% and GlcCer content to 30%. Simultaneous RNAi disruption of cgt-1 and cgt-3 resulted in an L1 lethal phenotype in the F1 worm, as described by Marza et al. (2009) , and the measurement was made on a worm population consisting mostly of L1-arrested or dying larvae. Neither cgt-1/cgt-2 nor cgt-2/cgt-3 double RNAi resulted in the lethal phenotype. cgt-2/cgt-3 double RNAi reduced the enzymatic activity to 14% and GlcCer level to 36% of the control ( Figure 1B ). GlcCer reduction was observed only when RNAi of cgt-3 was included in the experiments ( Figure 1B , white bars, P < 0.0001). Among the three cgt genes, inhibition of cgt-3 gene function resulted in the severest phenotypes (see below). These results showed that each gene codes active Ugcg and that the major Ugcg in the nematode is CGT-3 (F59G1.1).
Brood size reduction in RNAi-treated worms When WT worms were RNAi treated from L4 larva, single RNAi of each gene and double RNAi (cgt-1/cgt-2, cgt-2/cgt-3 and cgt-1/cgt-3) reduced brood size of the P0 worm significantly ( Figure 1C , white bars). The severest phenotypes were found (62% of the control for cgt-3 RNAi and 45% of the control for cgt-1/cgt-3 double RNAi) when cgt-3 was included in the RNAi (n = 20). When we continued the RNAi longer, to the F1 generation, the phenotypes became more severe, and a greater reduction in brood size was observed ( Figure 1C , black bars). The body size of the RNAi-treated worms was also reduced (not shown), and all the worms born from cgt-1/cgt-3 double-RNAi-treated hermaphrodites died at L1, with no egg-laying worms observed ( Figure 1C , cgt-3 + cgt-1).
Deletion mutants and their phenotypes
The longer the RNAi was continued, the more severe the brood size reduction. These results suggested that maternally inherited GlcCer and its derivatives were gradually decreased in successive generations under continuous RNAi treatment and that this decrease affected brood size reduction. To study the reduction in brood size under well-controlled conditions, we next isolated deletion mutant alleles of cgt genes by screening trimethylpsoralen/ultraviolet (TMP/UV) mutagenized libraries with appropriate oligonucleotide primers. The isolated cgt-1 KO strain (tm1027) and cgt-2 KO strain (tm1192) were viable. The cgt-3 KO worm strain (tm504) was also viable and showed the most severe defects among all of the isolated cgt KO worms. Analysis of gene structures of these deletion alleles indicated that these alleles are null alleles (Marza et al. 2009 ). The brood size of KO worms was reduced in all KO Glucosylceramide synthesis in germline and embryos worms ( Figure 2A , left graph, black bars, P < 0.01). The cgt-3 KO worm tm504 showed the most marked decrease in brood size among the KO worms. Its brood size was reduced to 58% of the WT animals (n = 20), and the body length was also reduced to 88% of the N2 worms (n = 40). Ugcg activity was reduced to 37% of WT worms ( Figure 2A , left graph, white bar). In all other cgt KO worms, a significant reduction in brood size and enzymatic activity was also observed (Figure 2A , left graph, black bars and white bars, respectively). To examine the GlcCer levels in these Ugcg KO worms, gravid hermaphrodites were collected from synchronized cultures, and GSLs were extracted and examined by thin-layer chromatography (TLC). Statistically significant reduction of GlcCer in each KO worm was confirmed ( Figure 2A , right graph, P < 0.05 for cgt-2 KO worm and P < 0.001 for cgt-1 or cgt-3 KO worm). Brood size reduction was well correlated with the reduction of GlcCer levels.
When GSLs were extracted from mixed-stage KO worms, reduction in GlcCer level was only observed in the cgt-3 KO worms. No reduction of GlcCer in the mixed-stage cgt-1 or cgt-2 KO worms was detected (not shown), and the result was consistent with the RNAi effects on GlcCer levels as shown in Figure 1B , where mixed-stage worms were used for the GlcCer level determination. GlcCer reduction was observed in the RNAi experiments only when the cgt-3 RNAi included. The results with the gravid KO worms strongly suggest that in the mixed-stage KO/knockdown worms of cgt-1 and/or cgt-2, the GlcCer synthesis by CGT-3 compensates for the decrease in other Ugcg gene products in the somatic tissues (see Germline-specific RNAi results in abnormal oocytes and abnormal embryonic cell division). The reduction in brood size and enzymatic activity was most apparent in the tm504 strain. This fact strongly suggests that CGT-3 is the major Ugcg in the germline, and the decrease in GlcCer levels in the germline for the compensation of CGT-1/CGT-2 may result in insufficient quantity of GlcCer in the germline, resulting in the brood size reduction in these mixed-stage animals. With this hypothesis in mind, further analysis was mainly carried out using the cgt-3 KO strain tm504.
Abnormal germline phenotypes in cgt-disrupted worms When carefully examined under a differential interference contrast (DIC) microscope, tm504 worms showed abnormalities in germline cells and in early embryos. In WT animals, the gonad acquires two U-shaped arms through directed migration of distal tip cells (DTCs) at the late L4 stage and later ( Figure 2B ). In about 5% of the tm504 worms (n = 224), arrest. **P < 0.01; *P < 0.05, two-tailed Student's t-test; † P < 0.05, one-tailed Student's t-test between P0 and F1 brood size. NS, not statistically significant. Error bars represent SD (n = 12). Brood size versus control value was reduced in P0 and F1 worms (P < 0.001; one-way ANOVA and Holm's multiple comparison test).
KH Nomura et al.
there were no oocytes or eggs in their gonadal arms although the vulva, an egg-laying organ of the nematode, seemed to be normally formed. In these worms, oocyte maturation seemed to be totally blocked, and no oocytes were observed ( Figure 2D ). Abnormal migration of gonadal arms (Mig phenotype) was observed in about 10% of the tm504 adult hermaphrodites ( Figure 2C ). In the uteri of about 12% of the tm504 worms, multinucleated lethal embryos were found among apparently normal embryos ( Figure 2E ). In most of the tm504 worms, there were abnormal oocytes and dying embryos, which explains the reduced brood size (Figure 2A ). When tm504 worms were fed with Escherichia coli for cgt-2 RNAi in which only cgt-1 gene activity is remnant, the number of lethal eggs per worm increased, and about 15% of the treated worms had lethal eggs (n = 20) ( Figure 2F ). This result suggests that the reduction of GlcCer affects the phenotype more drastically. In D. melanogaster, the extent of apoptosis is increased in Ugcg knockdown flies (Kohyama- Koganeya et al. 2004) . We carefully examined the increase in apoptotic cell death in gonadal arms in cgt-3 KO worms by acridine orange staining and by counting the apoptotic cell number. No increase in apoptotic cell number was detected in these worms. In addition, no abnormality in mitosis was detected when the mitosis marker histone H3 was examined in dividing germ cells (data not shown). From these experiments, we concluded that increasing the extent of The severest phenotype in tm504 worms. The vulva seemed normal (asterisk) but no oocytes and eggs were found in gonadal arms (white arrow heads). (E) A typical multinucleated egg (arrow) in a tm504 uterus. After fertilization at spermatheca, the egg failed in cleavage, and the multinucleated egg was formed and died. (F) Increase in abnormally cleaving eggs in tm504 worms treated with cgt-2 RNAi (F1 worms, RNAi-treated for 90 h). Number of abnormally cleaving eggs (arrows) among apparently normal eggs was increased. (G) bre-3 RNAi-treated tm504 worms. The number of abnormal eggs (arrow) in uterus was increased, but the number of worms with germline/reproductive system abnormalities was only slightly increased. Asterisk in (E), (F) and (G) indicates vulva. Scale bar, 100 μm.
Glucosylceramide synthesis in germline and embryos reduction in total Ugcg activity (by deletion mutagenesis and/ or by longer RNAi treatment) reduces the number of normal oocytes and eggs.
Transgenic rescue of the worms recovers abnormal phenotypes When the transgenic rescue experiment was performed on the tm504 strain with the WT cgt-3 genomic DNA, brood size of the worm was recovered to 78% of the normal (n = 10) and we obtained apparently normal hermaphrodites without any detectable defects (Supplementary data, Figure S1 , U and V).
From these results, we concluded that CGT-3 is the major Ugcg in the nematode and is needed in germline development.
Expression of cgt gene products Plasmids with enhanced green fluorescent protein (egfp)-fused cgt full-length genomic coding sequences were injected into N2 worms, and the expression patterns of cgt genes were examined. The CGT-1::EGFP was expressed in excretory canals, pharyngeal intestinal valve, intestine and intestinal rectal valve (Supplementary data, Figure S1A -H). CGT-2:: EGFP was expressed mostly in intestine and vulva (Supplementary data, Figure S1I -N). CGT-3::EGFP was expressed in pharyngeal intestinal valve, intestinal rectal valve and hypodermis (Supplementary data, Figure S1O -T). These results were the same as those of the previously published expression analysis, where no germline expression of the transgenically introduced cgt genes is detected (Marza et al. 2009 ). When transgenic DNA is introduced into the germline, the transgene is usually silenced by a transgenic silencing mechanism, which is presumed to be an innate immune mechanism to prevent foreign DNA from being expressed in the germline (Seydoux and Strome 1999; Strome et al. 2001 ). Absence of expression in the germline with this type of transgenic analysis does not mean that the gene is silent in the worm germline. When the copy number of the transgene is low or the complexity of the transgene is high, the transgenic silencing can be alleviated (Schaner and Kelly 2006) . Actually, in our transgenic rescue experiment, relatively weak but definite expression of the cgt-3 gene was detected in the germline. For instance, in the transgenically rescued animal ( Figure 3A and B), CGT-3::EGFP signal was clearly observed in the oocyte surface region. Spermatheca was also highly fluorescent in the rescued worm ( Figure 3B ), but no fluorescence was detected in the control ( Figure 3C and D). One possibility is that the weak expression of the cgt-3 gene in the germline is sufficient to rescue the germline phenotype of the tm504 deletion allele. Thus, we asked whether or not the cgt genes are transcribed in the germline of WT animals. Searching the in situ hybridization database (see NEXTDB online at http://nematode.lab.nig.ac.jp/) with cgt sequences revealed that the cgt-3 gene is expressed in the gonad of adult hermaphrodites. Serial analysis of gene expression (SAGE) by Wang et al. (2009) also showed that cgt-3 is among a set of 603 germline-specific/enriched genes identified only by SAGE. The germline tag of cgt-3 was 12 and the soma tag was only 5, indicating that the cgt-3 gene is enriched in the germline. In situ hybridization and SAGE analysis of the cgt genes showed that only cgt-3 is expressed in the germline.
Our rescue experiment strongly suggests that cgt-3 genomic sequence is transcribed in the germline, and expression of the gene in the germline rescued the abnormalities of the null allele. To confirm this directly, we examined the effects of cgt-3 RNAi treatment on the transgenically rescued line, but it was difficult to show the RNAi-mediated suppression of CGT-3::EGFP synthesis in the germline, because the silencing was difficult to distinguish from the loss of the transgene in the offspring and from the germline silencing. Thus, to examine whether cgt-3 RNAi suppresses expression of cgt-3 in the germline and results in abnormalities, we prepared a pie-1-driven cgt-3 genomic coding sequence. By ballistic bombardment, we generated an integrant cgt-3::gfp strain and analyzed the fluorescence. In an integrant strain, the germline silencing is usually circumvented and proteins expressed under control of the pie-1 regulatory sequences are typically present at 5-50% of the levels of the endogenous protein when analyzed by western blotting (Green et al. 2008) . As expected, in the integrant strain, bright GFP fluorescence was observed in gonads, oocytes, sperm, fertilized eggs and in intestine ( Figure 3E and F), and no fluorescent signals were found in the control ( Figure 3G and H). The somatic expression pattern of the integrated gene was the same as that of the cgt-3 extrachromosomal transgene, but in contrast to the results of the previously published transgenic analysis, strong fluorescence was observed in oocytes and in fertilized eggs. When the integrant strain was treated with cgt-3 RNAi, the signal in the intestine was weakened, and abnormally dying eggs with strong concentrated florescence signals were observed, indicating that the expression and distribution of CGT-3 was severely affected by RNAi ( Figure 3I and J). From these results, we concluded that cgt-3 mRNA is abundant in germline and cgt-3 RNAi results in knockdown of the germline expression of CGT-3.
Germline-specific RNAi results in abnormal oocytes and abnormal embryonic cell division Above experiments strongly indicated that the severe defects in oocyte formation and in early embryogenesis were resulted from cgt-3 inhibition in the germline. To confirm this, we next examined whether these phenotypes were the result of the suppression of cgt-3 gene activity in the germline or in somatic cells. To resolve this question, we used the somatic RNAi-resistant and germline RNAi-sensitive worm strain rrf-1 (NL2098). The gene rrf-1 encodes an RNA-directed RNA polymerase homolog required for somatic (but not germline) RNAi. By using this worm lacking somatic RNAi machinery, we could expect to suppress cgt activity solely in the germline (Grishok et al. 2005 ). The cgt-3 RNAi in the rrf-1 worm resulted in the same defects (13%, n = 15) in oocytes and early embryonic division ( Figure 4A ). When cgt-1 and cgt-3 double-RNAi treatment on rrf-1 worms was examined, germline phenotypes were confirmed again (14%, n = 28) ( Figure 4B ), but the L1 lethal phenotype was not observed at all, indicating that the somatic RNAi mechanism is involved in the L1 lethal phenotype and was absent in the rrf-1 worm. As described for tm504 cgt-3 KO worms, the body length of the cgt RNAi-treated worms was shortened in RNAi-treated N2 or OD70 worms, but in rrf-1 worms, body length was unaffected (not shown). The results indicate that L1 lethality and body size reduction are the somatic phenotypes and that oocyte/egg malformation is the germline phenotype. From these results, we concluded that cgt-3 mRNA is abundant in germline and that the protein CGT-3 is present in the germline.
Abnormal phenotypes in germline development and early embryonic cell division In the cgt-3 KO worms, we found many multinucleated dying eggs and abnormalities in oocyte formation. Because GlcCer and its derivatives, GSLs, are the important constituents of cell membrane, membranes of oocytes and eggs could be the major points of defects in Ugcg-disrupted animals. To visualize the cell membrane in these abnormal eggs and oocytes, we used OD70 worms, which have cell membranes that can be identified easily by their fluorescence. The strain contains a fluorescent marker mCherry DNA fused to a PH domain, which localizes to the cell membrane (Kachur et al. 2008 ). The RNAi treatment was continued for 120-136 h and the F2 progenies were carefully examined under a fluorescence microscope. The membranes in the cgt-3 RNAi-treated embryos emitted bright fluorescence where cell membrane formation was severely affected. In these affected eggs, no normal cell compartment in early division was formed. In cgt-3 RNAi-treated WT N2 worms, 8% of the worms showed membrane abnormality (n = 80), and in cgt-3 RNAi-treated OD70 worms, 12% of the worms showed this abnormality (n = 32) ( Figure 5A -C: cgt-3 RNAi). Multinucleated cells observed in this study looked similar to the defects produced when chondroitin proteoglycan synthesis is inhibited (Hwang et al. 2003; Mizuguchi et al. 2003; Izumikawa et al. 2004 ). The number of abnormal eggs increased to 14% when cgt-2 RNAi was combined with cgt-1 RNAi in N2 worms ( Figure 5D , n = 28) and 10% of cgt-1/cgt-2 double RNAi-treated OD70 worms showed the same defects ( Figure 5E and F, n = 42). When cgt-2/cgt-3 double RNAi Fig. 4 . Abnormal germline phenotypes in RNAi-treated rrf-1 (NL2098) worms. In this worm, the somatic RNAi machinery is deficient, and only germline-specific RNAi machinery is active. Many abnormal germline cells were observed when cgt-3 (A) or cgt-3/cgt-1(B) or bre-3 (C) gene function was suppressed with RNAi. Arrows in (A-C) indicate dying multinucleated eggs. bre-3 RNAi in an rrf-1 worm resulted in the Mig phenotype (D). Arrows in (D) indicate the abnormal route of gonadal arms. Asterisk indicates the vulva. Scale bar, 100 μm.
Glucosylceramide synthesis in germline and embryos was performed, the abnormality was found in 42% of the N2 worms ( Figure 5G , n = 14) and in 40% of the OD70 worms ( Figure 5H and I, n = 20). In dying eggs, the architecture of membranes was malformed, and strong, concentrated fluorescence was noted (arrows in Figure 5C , F and I). Similar experiments were carried out on ER fluorescent worms (WH0327), but no abnormality of ER was found in these worms (data not shown).
We crossed the OD70 worms with the β-tubulin reporter strain AZ244 and isolated a reporter strain (unc-119(ed3) III; itIs44V; ruIs57) with mCherry membrane fluorescence (red) and β-tubulin GFP fluorescence (green). The isolated strain was normal and the worm developed normally. No abnormalities were found for germline development and embryonic cell division ( Figure 6A and B). When this strain was treated with cgt-3 RNAi, abnormal cytokinesis of the fertilized eggs was prominent ( Figure 6C and D) . We monitored the embryonic cell division with time-lapsed DIC/fluorescence microscopy (4D microscopy). As shown in Figure 6 and the accompanying movies (Supplementary data, Videos S3 and S4), cytokinesis was severely affected and cleavage furrows were invaginated but they regressed without completing the furrow ingression. The nuclear division continued without normal cytokinesis. Because all the nuclei in the embryo seemed to be connected with β-tubulin (Supplementary data, Video S4), chromosome segregation seemed to be abnormal. The multinucleated eggs stopped development and eventually died.
In normal embryonic cell division (Supplementary data, Videos S1 and S2), pseudocleavage begins ( Figure 6A and B, 00:00 min) with ruffled movement of surface membranes and the egg pronucleus moves toward the sperm pronucleus ( Figure 6A and B, 02:00-04:00 min). After the fusion of the two pronuclei, 90°rotation of the nuclei begins within 6 min after the pseudocleavage, and the first cleavage furrow ingression is completed to form the two-cell-stage embryo about 12 min after the pseudocleavage ( Figure 6A and B, 04:00-12:00 min). In the cgt-3 RNAi-treated eggs, the ruffled membrane movement was observed as in the control embryos, but the pseudocleavage furrow formation was less prominent. The cell-cycle progression was greatly retarded and the first indication of the cleavage furrow ingression was observed after about 24 min (Figure 6C and D, (23) (24) :41 min, white arrows). The cleavage seemed insufficient and the cleavage furrow formation was not completed. The cleavage furrow ingression proceeded to the area where the midbody positions in normal embryos ( Figure 6C and D, 24:41-28:41 min, white arrows), but the ingression was incomplete and the furrow began to regress. Multiple nuclei were observed in the embryos ( Figure 6C, black arrowheads) . The progression of the cleavage furrow was apparently reversed (see Figure 6C and D, 24:41-36:42 min; Supplementary data, Videos S3 and S4). The cytokinesis failed in the embryo, and the embryo remained as a multinucleated one-cell embryo ( Figure 6C , arrowheads). As shown in Figure 6C and D (32:41-68:16 min) and in the accompanying movies, an attempt of the embryo to form cleavage furrow was repeated at around 52:42 min, and the extent of the furrow ingression reached the maximum at 68:16 min, but gradually the furrow regressed. The resulted embryo became multinucleated ( Figure 6C , 68:16 min). The cleavage furrow ingression was repeated several times afterward, but the ingression all failed and apparently multinucleated embryos were formed (128:08 min) and the embryos eventually died (13%, n = 87).
We also tested whether the gene disruption affects male gametogenesis or not. Males were obtained by heat shock from cgt-3 RNAi-treated N2 worms and mated with N2 hermaphrodites. The rate of appearance of males from this cross seemed to be normal, and the males from this cross were fertile. No abnormality in spermatogenesis was observed either in cgt-3 RNAi-treated worms or in the tm504 worms.
Cell surface expression of GSLs is decreased in the knockdown/KO worms We next examined whether the cell surface expression of GlcCer and its derivatives (GSLs) is really affected in cgt KO or RNAi-treated worms. As shown in Fig. 1 and Fig. 2 , the total GlcCer content in the cgt RNAi-treated or KO worms was reduced in these worms. Because there are few reliable probes useful for specific detection of GlcCer and GSLs on the cell surface, we used the bacterial toxin Cry5B to detect the loss of GlcCer and GSLs on the nematode cell surface. Cry5B belongs to the Crystal toxin family of proteins made by the bacterium Bacillus thuringiensis (Bt). It is a poreforming toxin, and Bt toxins are widely used as insecticides and nematocides. Cry5B binds to GlcCer and its derivatives (arthro series GSLs found in invertebrates) including Manβ1-4Glcβ1-Cer and GlcNAcβ1-3Manβ1-4Glcβ1-Cer. The toxin kills the worm expressing these GSLs (Griffitts et al. 2005) . Marroquin et al. (2000) isolated several C. elegans mutants (bre-1 to bre-5) resistant to this toxin. Analysis of the mutants revealed that bre-1 encodes GDP-mannose 4,6-dehydratase required for the synthesis of GDP-fucose, but bre-2 to bre-5 encode a series of enzymes necessary for the synthesis of GSLs. In our experiments, addition of the toxin to the WT worm killed them very effectively, but bre-3 RNAi-treated and cgt KO worms (all P0 worms) were resistant to the toxin and viable even as the toxin killed all WT animals ( Table I ). The tm504 strain and other cgt KO strains were not completely resistant to the toxin but survived longer than the WT strain N2. The survival rate of the tm504 animals was about 21% which is lower than that of cgt-1 or cgt-2 KO strains. This difference may be the result of the fragile condition of the cgt-3 KO worms combined with the presence of residual GlcCer synthesized by intact CGT-1 and CGT-2. Resistance to the bacterial toxin Cry5B indicates that RNAi and gene KO reduced cell surface expression of GlcCer and GSLs. 
Glucosylceramide synthesis in germline and embryos
Inhibition of ManGlcCer synthase by RNAi results in similar phenotypes
We next asked whether the phenotypes described in the present study are also caused by inhibiting synthesis of arthro series GSLs synthesized by bre-3, bre-5, bre-4 and bre-2. The bre-3 gene product is a GDP-Man:Manβ1-4Glcβ1-Cer β1,4-mannosyltransferase, which shows high sequence similarity to the Drosophila gene egghead and catalyzes elongation of the GSL chain by synthesizing the stub structure for all arthro series GSLs elongated by successive addition of sugars by bre-5, bre-4 and bre-2 (Marroquin et al. 2000) . Germline SAGE experiments have revealed the presence of bre-3, bre-4 and bre-5 gene expression in the germline, but they were not enriched as was cgt-3 (Wang et al. 2009 ). If we applied bre-3 RNAi on N2 worms, about 5% of the treated F2 worms showed defects in oocytes and eggs ( Figure 5J , n = 40) and bre-3 RNAi on OD70 worms resulted in the abnormalities in 7% of the worms ( Figure 5K and L, n = 84). In the experiment described in Figure 2 , cgt-2 RNAi on tm504 worms resulted in about 15% of the worms showing abnormalities. If the cgt-2 RNAi was replaced with bre-3 RNAi and when bre-3 function was disrupted in tm504 worms, no comparable increase in abnormality was observed and less than 14% of the worms showed the abnormalities ( Figure 2G , n = 36). The bre-3 RNAi treatment of the rrf-1 worms also resulted in abnormal eggs and embryos ( Figure 4C ) as well as the Mig phenotype ( Figure 4D) . Thus, the phenotypes of bre-3 knockdown worms were similar to those of the cgt-3 knockdown/KO worms although the percentage of affected eggs was lower than the former. The results suggest that the phenotypes caused by cgt-3 disruption are mostly the result of an absence of GSLs. Deletion alleles of bre-5, bre-4 and bre-2 did not result in oocyte and early embryonic cell division defects (not shown), indicating that the presence of GlcCer and Manβ1-4Glcβ1-Cer is needed for oogenesis and early embryonic cell division.
Sphingomyelin on cell surface increases under Ugcg inhibition
Lipid rafts or membrane nanodomains are enriched mainly by sphingomyelin (SM), GSLs synthesized from GlcCer, cholesterol and glycosylphosphatidylinositol (GPI)-anchored proteins. SM is a major plasma membrane lipid that forms the lipid nanodomains or rafts (Lingwood and Simons 2010) . Because loss of cholesterol (Matyash et al. 2004) or inhibition of GPI-anchor synthesis (D Murata et al., in preparation) results in similar germline defects and cell division, these defects may be resulted from abnormalities in lipid domainmediated signal transduction. Thus, to gain mechanistic insights for the role of GlcCer synthase in the observed phenotypes, we examined whether SM distribution is affected under Ugcg inhibition or not ( Figure 7A-I ). For detecting SM on the cell surface, we used a protein toxin lysenin that specifically recognizes SM and is widely used as an SM probe (Kiyokawa et al. 2005) . The GFP-NT-Lysenin, which is a GFP-tagged nontoxic form of lysenin, binds clustered SM specifically (Ishitsuka et al. 2004 ). We stained the dividing embryos with anti-α tubulin antibody (Kodama et al. 2002) to identify two-cell-stage embryos at the same stage of cell division ( Figure 7B , E and H), and simultaneously stained them with GFP-NT-Lysenin. The GFP-NT-Lysenin stained two-cell-stage normal embryos ( Figure 7A and C). Compared with the nontreated worms, brighter staining was consistently observed in Ugcg knockdown worms, indicating the changes of SM distribution in the worms (P < 0.01, one-way ANOVA and Holm's multiple comparison test, n = 13). The fluorescence signal increased in cgt-3 RNAi-treated two-cell-stage embryos ( Figure 7D and F) . The signal became stronger with the enhanced RNAi treatment (cgt-2/cgt-3 double RNAi) ( Figure 7G and I) . In a typical experiment ( Figure 7C , F and I), fluorescence intensity was 708 a.u. (arbitrary units) in the normal embryo, while it increased to 1008 a.u. in the cgt-3 RNAi-treated embryo, and to 1590 a.u. in the cgt-2/cgt-3 double RNAi-treated embryo. The bright SM staining indicates that the SM distribution on the surface of these cells was changed markedly by the RNAi treatment. Thus, inhibition of Ugcg synthesis resulted in increased expression of clustered SM on the cell surface of blastomeres, indicating disturbance of membrane domains under Ugcg inhibition.
Discussion
The C. elegans genome has three Ugcg genes, and we showed that each gene product has enzymatic activity in vivo and in vitro. The penetrance of the lethality under cgt gene inhibition was not 100% and was subvital (10-50% lethality, Table I . Effects of Cry5B toxin on worm survival
JM103
Cry5B Cry5B + bre-3 RNAi N2 100% (n = 10) 0% (n = 20) 100% (n = 20) cgt-1 (tm1027) 92% (n = 14) 68% (n = 22) 100% (n = 19) cgt-2 (tm1192) 100% (n = 15) 33% (n = 9) 100% (n = 9) cgt-3 (tm504) 88% (n = 9) 21% (n = 19) 100% (n = 17)
Values indicate percentage of surviving worms in plates at 5 days after addition of the toxin. KH Nomura et al.
detrimental mutation). The cgt-3 gene encodes the most active enzyme and seems to be the major Ugcg gene in the nematode. Although the loss of cgt-3 by deletion mutagenesis reduced the total GlcCer content in the worm, two other active enzymes remain, and their gene products may partially (but not completely) compensate for the decrease in GlcCer content; this backup mechanism may enable many germ cells and embryonic cells to escape lethality although the total GlcCer content is not enough for all germline cells to mature and divide normally. cgt-1/cgt-3 double knockdown resulted in an F1 lethal phenotype (100% penetrance), and all the double KO worms died at the L1 stage. The timing of the death at L1 coincides well with the beginning of gonad formation (appearance of gonadal primordium containing Z1-Z4 cells). Abnormal migration of DTCs in cgt-3 KO worms and bre-3 RNAi-treated worms suggests that a sufficient quantity of GlcCer and/or its derivatives is necessary for DTC migration. These results strongly suggest that GlcCer synthesis is necessary for the development of the somatic reproductive system at the juvenile stage of the worm. cgt-2/cgt-3 double knockdown resulted in normal worms although the brood size was relatively reduced. cgt-1/cgt-2 double knockdown did not affect lethality, indicating that active cgt-3 product plays a major role in the synthesis of GlcCer and that cgt-1 is also essential for larval development. In tm504 (cgt-3 KO) worms, the other two enzymes CGT-1 and CGT-2 can compensate for the disruption of cgt-3; thus, we cannot expect 100% lethality nor 100% penetrance of the oocyte/egg phenotypes. Reinke and Cutter (2009) showed that almost all operon-encoded genes are expressed in germline tissues but that genes expressed during spermatogenesis are excluded from operons. The cgt-3 gene is unique among other cgt genes in that it is in the operon CEOP2232 with seven other genes: F59G1.4, tsp-18 (F59G1.2), F59G1.8, vps-35 (F59G1.3), cgt-3, frataxin (frh-1:F59G1.7), ptp-2 (F59G1.5) and vrk-1 (F28B12.3) (Vazquez-Manrique et al. 2007; Reinke and Cutter 2009) . The operon structure is highly conserved through the Caenorhabditis genus. In the C. elegans, C. briggsae and C. remanei genomes, six out of the eight genes (F59G1.4, vps-35, cgt-3, frh-1, ptp-2 and vrk-1) are highly conserved and are located in the same order and with similar mutual distances (Vazquez-Manrique et al. 2007 ). Except for F59G1.4, these highly conserved genes are germline expressed (Vazquez-Manrique et al. 2007; Wang et al. 2009 ), and inhibition of each gene results in various germline phenotypes. vps-35 (F59G1.3) encodes a protein forming a retromer complex with other proteins and is involved in retrograde transport of intracellular sorting receptors and mammalian mannose 6-phosphate receptors from endosomes to the trans-Golgi network (Seaman 2005) . The frh-1 gene encodes a frataxin gene, and PTP-2 is an SH2 domain-containing nonreceptor protein tyrosine phosphatase and is required for oogenesis, fertility and embryonic development through let-60/Ras pathway. VRK-1 belongs to the Vaccinia-related kinase family and is essential in hermaphrodites for formation of oocyte, egg, vulva, uterus and utse (uterine seam), and for development and maintenance of the somatic gonad (Vazquez-Manrique et al. 2007 ). As we showed in this paper, cgt-3 is involved in oocyte development and early embryonic cell division. Although transgenic expression analysis suggests that these genes in CEOP2232 are not expressed synchronously (Reinke and Cutter 2009) , it is an intriguing possibility that these operon-coded genes are involved in oocyte development and early embryonic cell division with cgt-3.
In cgt-deficient hermaphrodites, among apparently healthy oocytes and fertilized eggs are oocytes and eggs with disturbed membrane and nuclei. Lochnit et al. (2005) previously reported that RNAi for cgt-1, cgt-2 or cgt-3 in liquid cultures results in brood size reduction, and various inhibitors of GlcCer synthesis result in the arrest of development. Their findings are consistent with ours, and the slight difference between the outcomes may be attributable to the difference in worms used for RNAi (N2 and rrf-3) and their stage synchronization with hypochlorite solution. The treatment sometimes causes physical damage to the worm and often results in abnormality in growth in our hands (not shown). By using cgt RNAi on OD70 membrane fluorescent worms, we revealed that the membrane of the abnormal oocytes and eggs in cgt-3-disrupted worms was severely affected. Examination of the distribution of SM, which is an essential component of membrane, revealed that SM expression was drastically elevated in the RNAi-treated abnormal embryos. This is the first demonstration of SM elevation in ovo in Ugcg-depleted animals, although SM elevation in vitro has been reported in Ugcg-depleted GM95 cells . Yokoyama et al. (1997) reported that SM synthesis is suppressed and GlcCer accumulates in mitotic HeLa cells. In the two-cell-stage embryos reported in this study, GlcCer expression was reduced and SM expression was elevated, and the affected embryos showed abnormal mitosis resulting in multinucleated embryos. These results and the Cry5B susceptibility experiments clearly indicate that surface membrane of the abnormal embryos were severely affected by Ugcg inhibition. It is reasonable to assume that for normal membrane formation in oocytes and eggs, GlcCer and complex GSLs derived from it are essential and the absence of the most active GlcCer synthesizing enzyme CGT-3 causes insufficient GlcCer and GSL supply for use in all the oocytes and eggs. Oocytes and eggs with insufficient GlcCer and its derivatives may show these defects in cell membrane formation and apparent abnormalities in cell-cycle progression and cell division. The results strongly suggest that for normal cell-cycle progression, the synthesis of GlcCer and GSLs derived from it are essential in C. elegans.
We next asked whether a decrease in GlcCer or decrease in ManGlcCer and other GSLs resulted in these phenotypes. One possible way to test this is to block ManGlcCer synthesis and see the effects. ManGlcCer is the nematode replacement of lactosylceramide (LacCer) in higher organisms, and there is no LacCer in C. elegans. ManGlcCer is synthesized by the GlcCer mannosyltransferase (bre-3) gene product and we confirmed that inhibition of bre-3 by RNAi resulted in Cry5B toxin resistance, showing that ManGlcCer is lost in the bre-3 RNAi-treated worms. In these worms, the germline phenotype was apparent and its penetrance was less than 7%. The results, together with the results with deletion alleles of bre-5, bre-4 and bre-2, strongly suggest that the synthesis of GlcCer and ManGlcCer is essential for oocytes and early embryonic Glucosylceramide synthesis in germline and embryos cells to proceed through the normal cell division. Detailed analysis of the bre-3 deletion mutant is underway in our laboratory.
Ugcg is also essential in mouse (Yamashita et al. 1999 ) and Drosophila development (Kohyama-Koganeya et al. 2004 ), but it is dispensable in GM95 cultured cells . One possibility is that Ugcg is dispensable in twodimensionally growing cultured cells but is essential in formation of three-dimensional (3D) oocyte/egg structures. For constructing 3D membrane structures, more membrane components are needed than to form 2D membrane structures, and especially in rapidly cleaving embryos, an ample quantity of membrane components must be supplied quickly to form newly cellularized oocyte membranes and rapidly cleaving embryonic membranes. A rapid and ample supply of GlcCer and its derivatives may be essential for all of the oocytes and eggs to develop quickly. The postulated compensation of GlcCer by SM may be insufficient in such conditions.
We have shown that the C. elegans genome contains three active GlcCer synthase genes and that the cgt-3 gene encodes the enzyme with the most significant activity, while the other two enzymes seem to act to complement the cgt-3 activity when the gene is disrupted. We performed psi-blast searches for GlcCer synthase in various genomes including nematode, human, mouse and Drosophila. With the exception of the C. briggsae and C. remanei genomes having two GlcCer synthase genes, human, mouse and Drosophila genomes contain only one. For nematodes, having multiple genes may confer a survival advantage in their niche. We know that some fungi produce inhibitors of the GlcCer synthetic pathway (e.g. ISP-1, a potent inhibitor of serine palmitoyltransferase that synthesize the precursor of GlcCer; Takematsu and Kozutsumi 2006) and that under such conditions, having multiple cgt genes may confer an advantage for survival. In contrast, knocking out cgt resulted in resistance to the bacterial toxin Cry5B, indicating that regulation of the cell surface GSL level could be used as an innate immune response to pathogens (Ideo et al. 2009 ). Many laboratories have found that human tumor cells showing multidrug resistance (MDR) exhibit high GlcCer synthase activity, and the relationship between GlcCer synthase and MDR has attracted great attention (Lavie et al. 1996; Morjani et al. 2001; Sun et al. 2006; Liu et al. 2008; Ruckhaberle et al. 2009; Zhang et al. 2009 ). The nematode having three different CGT enzymes could be studied as a model of GSL-mediated innate immunity and a model of MDR when antitumor drug candidates are added.
Materials and methods
Materials C6-NBD-GlcCer was obtained from Sigma (Tokyo, Japan). All other reagents were of the highest purity available. E. coli strains JM103[ pQE9] and JM103[ pQE9(Cry5B)] were kindly provided by Raffi V. Aroian (University of California, San Diego, CA). GFP-NT-Lysenin (GFP-tagged nontoxic lysenin) was a kind gift from Dr. Toshihide Kobayashi (RIKEN Advanced Science Institute, Saitama, Japan).
Nematode strains
All worm strains were cultured under standard condition (Brenner 1974) . The following strains were used: N2, wildtype (WT); OD70, ltIs44pAA173 [ pie-1p-mCherry::PH (PLC1delta1) + unc-119(+)] (Kachur et al 2008) ; NL2098, rrf-1( pk1417) I (Sijen et al. 2001 ); AZ244, unc-119(ed3) III ruIs57[ pie-1::GFP::tubulin + unc-119(+)] (Praitis et al. 2001 ). These were obtained from the Caenorhabditis Genetics Center, and WH0327: unc-119(ed3);ojIs23[SP12::GFP unc-119(+)] was obtained from the White Lab (Dr. J. G. White, University of Wisconsin, Madison, WI). Strains coexpressing GFP-labeled β-tubulin marker along with the mCherry membrane probe were generated by mating OD70 to AZ244, and one strain with the brightest fluorescence was selected and used in this study.
Deletion mutagenesis
The deletion mutant strains tm1027 (T06C12.10 cgt-1 −/− ), tm1192 (F20B4.6 cgt-2 −/− ) and tm504 (F59G1.1 cgt-3 −/− ) were isolated from pools of worms mutagenized by a combination of treatment with the chemical mutagen TMP and UV light, and were identified by detecting polymorphisms in the length of the PCR product, as described previously (Gengyo-Ando and Mitani 2000) . The primers used for the screening and genotyping of the deletion alleles were as follows. For tm1027: ExtFwd, 5′-CCCATTCCTAAA AACAC TGC-3′;
ExtRev, 5′-ACAACTTCCTTCAGTCAGAG-3′; IntFwd, 5′-GGATGTTTCCAAACTTTCGG-3′; IntRev, 5′-GA TATTTCGTGCAGAAGCTC-3′. For tm1192: ExtFwd, 5′-CC ACGCATCTTATGGCTGTA-3′; ExtRev, 5′-GAAAGTA TCG ACTCCACCGT-3′; IntFwd, 5′-TGCAGAAGGGAAGCA ATCCT-3′; IntRev, 5′-CCAACCCTTCACTACCCGGA-3′. For tm504:
ExtFwd, 5′-GACGCCTTTTCAGTGCAAAT-3′; ExtRev, 5′-GGTGATATAAATTACATAGTTGGA-3′; IntFwd, 5′-CTTGGCAGGTGTGAACATAG-3′; IntRev, 5′-GTTGGA ATTTTTCTGAACCTGA-3′. Because all the mutants were viable, they were outcrossed four times and used for the study.
RNAi by feeding
The protocol for RNAi by feeding was based on the described methods (Mizuguchi et al. 2003; Dejima et al. 2006) . Feeding strains of T06C12.10 (cgt-1), F20B4.6 (cgt-2) and B0464.4 (bre-3) were obtained from the Ahringer Feeding Library (Kamath et al. 2003) . The cDNA clone for F59G1.1 (cgt-3) was amplified by PCR from total cDNA of N2 worms. Primers for the F59G1.1 cDNA were as follows. Fwd: 5′-ATGGCAGCTCAGCTTGATGT-3′; Rev: 5′-ACATTTT GGTGGAAGTATCTGTC-3′. A fragment of cDNA was cloned into the L4440 ( pPD129.36) vector, and the cloned plasmids were transformed into E. coli HT115 (DE3). A single colony of HT115 (DE3) containing the plasmid was grown in LB culture medium for 8 h and seeded onto nematode growth medium (NGM) agar plates (80 μL/plate), which were incubated at 37°C overnight. Following the addition of 2 mM isopropyl β-D-thiogalactopyranoside (100 μL/plate), the cells were cultivated for 4 h to induce expression of doublestranded RNA (dsRNA). HT115 harboring the plasmid pPD129.36 without any insert was used as control. For phenotypic characterization and the assay of lethality, L4 KH Nomura et al. hermaphrodites were transferred onto the plates, and dsRNA was introduced into the worms by feeding. For assaying Ugcg enzymatic activity and quantifying GlcCer content, worms were maintained at 25°C for 60 h before analysis. F1 and F2 progenies were further incubated for 130 h and observed by microscopy.
cDNA cloning of C. elegans cgt The complete open-reading frames for cgt1 (T06C12.10), cgt2 (F20B4.6) and cgt3 (F59G1.1) were amplified from a cDNA library derived from C. elegans using specific primers containing restriction sites and an extended Kozak sequence in front of the start codon. Primers were as follows: for cgt-1, Fwd:
5′-ATTGGATCCATGGAGGCTGCCAACGAAGTG G-3′ and Rev: 5′-CCGCTCGAGAACGGCTCCT TTCG ATAATGAAAC-3′; for cgt-2, Fwd: 5′-TACGGA TCCAT GGG CGATAAAATAACCGG-3′ and Rev: 5′-GCCCG GAATTCA ATTGAAGTTTGACTGCGAA-3′; and for cgt-3, Fwd: 5′-CGCGGATCCATGTGTAAATATGGAAAATCAAA CTTG GC-3′ and Rev: 5′-CCGCTCGAGACATTTTGGT GGAAG TATCTGTCCACC-3′.
The PCR product was subcloned into pcDNA3.1/Myc-His (+) (Invitrogen).
Cell culture and transfection Ugcg-deficient mutant cells, GM95, were obtained from B16 melanoma cells after mutagenesis (Ichikawa et al. 1994 ). Cells were cultured at 37°C in minimal essential medium supplemented with 10% fetal bovine serum, 100 μg/mL streptomycin and 100 units/mL penicillin in a humidified incubator containing 5% CO 2 . cDNA transfection was carried out using Lipofectamine™ Plus (Invitrogen) according to the manufacturer's instructions.
Assay of Ugcg activity
Ugcg activity was assayed according to the method of Ichikawa et al. (1996) with slight modification. C6-NBD-Cer (500 pmol) and lecithin (5 μg) were mixed in 50 μL of ethanol and the solvent was evaporated. A total of 10 μL of water was added and the mixture was sonicated to form liposomes. Fifty microliters of the reaction mixture contained 50 mM Tris-HCl ( pH 7.5), 500 μM UDP-Glc, 1 mM ethylenediaminetetraacetic acid, 10 μL C6-NBD-Cer liposome and 20 μL of an appropriate amount of protein and was incubated at 25°C for 3 h. A total of 100 μL of chloroform/methanol (2:1, v/v) was then added to terminate the reaction, and the lower layer was applied to TLC plates, which were then developed with chloroform/methanol/water (65:25:4, v/v/v). The NBD-GlcCer produced was detected and quantified using a Shimadzu CS-9300 chromatoscanner (excitation 475 nm, emission 525 nm).
Glycolipid extraction of cgt mutants Lipids were extracted from 300 μL (1.5 mg protein) of WT and cgt mutant worms with 600 μL of chloroform/methanol (1:1, v/v). The lower layer was dried using Speed Vac concentrator, dissolved with 100 μL of 0.1 N NaOH in methanol at 37°C for 1 h. The sample was neutralized with 10 μL of 1 N HCl, and sphingolipids were extracted from the lower phase with 200 μL of chloroform and 60 μL of water. The lower layer was applied to TLC plates, which were then developed with chloroform/methanol/water (65:25:4, v/v/v) . Glycolipids were visualized by spraying TLC plates with orcinol-H 2 SO 4 reagent and quantified with Shimadzu CS-9300 chromatoscanner with the reflectance mode set at 540 nm.
Quantifying GlcCer of cgt-knockdown worms GlcCer was quantified according to the method of Zama et al. (2009) . Lipids were extracted from 180 μL (200 μg protein) of WT and cgt-knockdown worms with 600 μL of chloroform/ methanol (2:1, v/v). The lower layer was dried using Speed Vac concentrator, dissolved with 200 μL of 0.1 N NaOH in methanol at 37°C for 1 h. The sample was neutralized with 20 μL of 1 N HCl and washed with 200 μL of hexane thrice. Crude sphingolipids were extracted from the lower phase with 400 μL of chloroform and 150 μL of water. The chloroform layer was dried and dissolved in 30 μL of 25 mM sodium acetate buffer ( pH 5.5), containing 5 mM CaCl 2 , 2% Triton X-100 and 150 μU SCDase (sphingolipid ceramide N-deacylase). The recombinant Schewanella SCDase was prepared as described (Furusato et al. 2002) . Following incubation at 37°C overnight, the reaction was stopped with 600 μL of chloroform/methanol (2:1, v/v) and 150 μL of water. The lower phase was dried using a Speed Vac concentrator and dissolved in 120 μL of ethanol. The ethanol solution was derivatized at 37°C for 30 min by 15 mL of ortho-phthalaldehyde (OPA) reagent [0.1 mL of ethanol containing 10 mg of OPA, 20 μL of 2-mercaptethanol and 9.9 mL of 3% boric acid, pH 10.5]. The sample was then injected into high-performance liquid chromatography.
Scoring phenotypes
We determined brood size and the extent of lethality of cgt RNAi-treated worms and the cgt deletion mutants as follows. The worms were picked at late L4 stage from culture plates, allowed to lay eggs for 24 h, and then transferred to a new plate daily for the next 3 days. Larvae that failed to develop into L3 after 40 and 96 h were scored as larval arrest/lethal at 25°C. For measuring body length, three L4 worms of N2 or deletion mutant tm504 each were put onto a 60-mm plate and fed for 96 h at 20°C before analysis. We collected 40 adult worms on a slide glass for each experiment and heated the worms for 1 min at 60°C and measured their linear body lengths by ocular micrometer.
Transgenic experiments
Full-length cgt genes were amplified from genomic DNA. Primers were as follows: for cgt-1, Fwd: 5′-CAAAGCCT CCGTGTTTCTG-3′, Rev: 5′-AACGGCTCCTTTCGATA ATG-3′; for cgt-2, Fwd: 5′-AATTTCGTGAATT GCATGTTTT-3′, Rev: 5′-AATTGAAGTTTGACTGCGAA TTTT-3′; and for cgt-3, Fwd: 5′-ACATGGATTCAAT GCACGAG-3′, Rev: 5′-ACATTTTGGTGGAAGTATCTGTC-3′. Amplified products were cloned into vector pFX_EGFP as described (Dejima et al. 2010) . Expression constructs and a co-injection marker pRF4 were injected at 5 and 93 ng/μL, Glucosylceramide synthesis in germline and embryos respectively. The amplified gene and the roll marker pRF4 were microinjected into N2 for expression analysis and into tm504 for the rescue experiment using cgt-3.
Germline integration of CGT-3::EGFP by ballistic bombardment Full-length cgt-3 was amplified from genomic DNA. Primers for the cgt-3 genomic DNA were 5′-TAGACTAGTATGGA AGTTGCAAAAGCCG-3′ and 5′-TAGACGCGTACATTTT GGTGGAAGTATCT-3′. The amplification product was cloned into the plasmid pJK7 obtained from the White Lab. The plasmid was then bombarded into unc-119 worms as described (Praitis et al. 2001) . Worms were then allowed to grow for at least 2 weeks, and the rescued worms were examined for GFP expression.
Oocyte/egg observation and lysenin staining Live worms were anesthetized with 16 mM sodium azide solution, placed on an 8-well printed microscope slide glass (Matsunami Glass) and examined using microscopy (OLYMPUS BX51 with DIC and fluorescence optics as described; Dejima et al. 2006) . For gonad observation, cgt-3::EGFP transgenic worms were cut open in M9 buffer (Izumikawa et al. 2004 ) on an 8-well printed microscope slide glass and the gonads were pulled out and examined using microscopy. For lysenin/tubulin double staining, gonads of the worms were dissected out in M9 buffer and put on a microscope slide glass (Matsunami Glass) and were covered with an 18 mm × 18 mm coverslip (Matsunami Glass). The worms were freeze-cracked and fixed in methanol at −20°C for 2 min. They were immediately transferred to phosphate-buffered saline (PBS) to avoid drying. The slides were then washed twice in fresh PBS for 5 min, and then they were blocked with 1% bovine serum albumin in PBS for 30 min at room temperature. GFP-NT-Lysenin (Kiyokawa et al. 2005 ) (the final concentration of 20-50 nM) and mouse anti-α-tubulin antibody DM1 (Sigma) diluted in PBS (1:1000) (Kodama et al. 2002) were applied and the specimens were incubated for 2 h at room temperature in a dark humidified chamber. After the incubation, the slides were washed thrice in PBS for 5 min, and then they were incubated with a secondary antibody [anti-Mouse IgG Alexa-Fluor 594 diluted in PBS (1:400), the final concentration of 5 μg/mL] for 45 min. Additionally, the slides were washed thrice in PBS for 10 min and mounted in VECTASHIELD Mounting Medium (Vector Laboratories). The images were processed using MetaMorph software (version 6.1r5; Universal Imaging) and the average fluorescence intensity was measured using the software after subtracting the background value of the CCD camera (PCO SensiCAM QE, PCO.imaging, Germany).
Four-dimensional microscopy
We use MetaMorph Software (Molecular Device Corp., USA) for controlling the OLYMPUS BX51 microscope and the CCD camera described above to capture and analyze 4D images. The microscope was equipped with MAC 5000 controller system (Ludl Electronic Products Ltd., USA) which controls a z-axis motor, two filter wheels with shutters and an automatic XY stage (BioPrecision XY stage, Ludl., USA). The dsRNA-treated mother worms coexpressing GFP-labeled β-tubulin marker along with the mCherry membrane probe were dissected in M9 buffer, and the eggs were collected and put on an 8-well printed microscope slide glass (Matsunami Glass) for microscopy. We recorded the developing embryos at 20°C for 8-10 focal planes, at a distance of 1-2 μm between adjacent focal planes and at intervals of 60-120 s for 0.5-3 h under DIC or epifluorescence (GFP and mCherry) illumination. The data were acquired with the CCD camera, and movies were made from the raw data using the MetaMorph software.
Cry5B toxicity assay by feeding For the toxicity assay, a saturated overnight culture of E. coli JM103[ pQE9(Cry5B)] was seeded onto an NGM agar plate (80 μL/plate) followed by incubation at 37°C overnight. Following the addition of 2 mM isopropyl β-D-thiogalactopyranoside, the cells were cultivated for 6 h at 37°C to induce expression of the toxin. N2 and deletion mutants at the L4 stage were put onto the plates and incubated by day 5 and examined every 24 h. JM103 cells having empty plasmids were the controls. The protocol was modified from our previous paper (Ideo et al. 2009 ). For the toxicity assay on bre-3 RNAi-treated worms, P0 worms were bre-3 RNAi-treated for 44 h, and the born L4 worms were put onto the NGM agar plates. The NGM agar plates for the assay were prepared as follows: Before seeding the worms, the NGM agar plates were seeded with bre-3 RNAi bacteria (40 μL/plate) and E. coli JM103[ pQE9(Cry5B)] (40 μL/plate) and incubated at 37°C overnight. After addition of 2 mM isopropyl β-D-thiogalactopyranoside, the cells were cultivated as above to induce expression of the toxin. Survival rates were scored at 24 h intervals for 5 days.
